Characterization of blood-borne transmission of simian foamy virus

Transfusion

Volumn 47, Issue 1, 2007, Pages 162-170

  Brooks, James I ^a   Merks, Harriet W ^b   Fournier, Jocelyn ^b   Boneva, Roumiana S ^b   Sandstrom, Paul A ^b  

^a Bur HIV/AIDS STD TB LCDC HPB H   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD TRANSFUSION; CONTROLLED STUDY; CORRELATION ANALYSIS; FOLLOW UP; IMMUNE RESPONSE; IMMUNOREACTIVITY; MONKEY; NEWBORN; NONHUMAN; QUANTITATIVE ANALYSIS; SALIVA; SEROCONVERSION; SIMIAN FOAMY VIRUS; SIMIAN VIRUS; T LYMPHOCYTE ACTIVATION; VASCULARIZATION; VIRUS DETECTION; VIRUS INFECTION; VIRUS INFECTIVITY; VIRUS SHEDDING; VIRUS TRANSMISSION;

ANIMALS; BLOOD; BLOOD TRANSFUSION; CD4-CD8 RATIO; COMPUTER SYSTEMS; DNA, VIRAL; FLOW CYTOMETRY; LYMPH NODES; LYMPHOCYTE COUNT; MACACA FASCICULARIS; RETROVIRIDAE INFECTIONS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SALIVA; SPUMAVIRUS; TIME FACTORS; VIRAL LOAD; VIRUS SHEDDING;

EID: 33845792092     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2007.01079.x     Document Type: Article

References (33)

1. Heneine W, Switzer WM, Sandstrom PA, et al. Identification of a human population infected with simian foamy viruses. Nat Med 1998;4:403-7.
2. Brooks JI, Rud EW, Pilon RG, et al. Cross-species retroviral transmission from macaques to human beings. Lancet 2002;360:387-8.
3. Switzer WM, Bhullar V, Shanmugam V, et al. Frequent simian foamy virus infection in persons occupationally exposed to nonhuman primates. J Virol 2004;78:2780-9.
4. Wolfe ND, Switzer WM, Carr JK, et al. Naturally acquired simian retrovirus infection in central African hunters. Lancet 2004;363:932-7.
5. Hahn BH, Shaw GM, De Cock KM, et al. AIDS as a zoonosis: scientific and public health implications. Science 2000;287:607-14.
6. Achong BG, Mansell PW, Epstein MA, et al. An unusual virus in cultures from a human nasopharyngeal carcinoma. J Natl Cancer Inst 1971;46:299-307.
7. Schweizer M, Falcone V, Gange J, et al. Simian foamy virus isolated from an accidentally infected human individual. J Virol 1997;71:4821-4.
8. Blood Safety Surveillance and Health Care Acquired Infections Division, Centre for Infectious Disease Prevention and Control. Preliminary risk assessment on simian foamy virus (SFV) and deferral policy for blood and CTO donation [monograph on the Internet]. Winnipeg, Manitoba: Public Health Agency of Canada; 2004. Available from: http://www.phac-aspc.gc.ca/id-mi/sfv-vss- 20041021ra_e.html
9. Blood Products Advisory Committee. Topic II: The potential risk of simian foamy virus transmission by blood transfusion [monograph on the Internet]. Gaithersburg (MD): U.S. Food and Drug Administration; 2004. Available from: http://www.fda.gov/ohrms/dockets/ac/04/briefing/2004-4074b1_02_topic%202.pdf
10. Boneva RS, Grindon AJ, Orton SL, et al. Simian foamy virus infection in a blood donor. Transfusion 2002;42:886-91.
11. Schweizer M, Neumann-Haefelin D. Phylogenetic analysis of primate foamy viruses by comparison of pol sequences. J Virol 1995;207:577-82.
12. Terao K, Fujimoto K, Cho F, et al. Detection of ABO group specific substances on the red cells of the cynomolgus monkey. Jpn J Med Sci Biol 1981;34:1-7.
13. Socha WW, Blancher A, Moor-Jankowski J. Red cell polymorphisms in nonhuman primates: a review. J Med Primatol 1995;24:282-305.
14. Hahn H, Baunach G, Bräutigam S, et al. Reactivity of primate sera to foamy virus Gag and Bet proteins. J Virol 1994;75:2635-44.
15. Protein blotting application guide. Bedford (MA): Millipore Corp.
16. Meiering CD, Linial ML. Historical perspective of foamy virus epidemiology and infection. Clin Microbiol Rev 2001;14:165-76.
17. Gregory TR. Nucleotypic effects without nuclei: genome size and erythrocyte size in mammals. Genome 2000;43:895-901.
18. Mandy FF, Nicholson JK, McDougal JS; CDC. Guidelines for performing single-platform absolute CD4+ T-cell determinations with CD45 gating for persons infected with human immunodeficiency virus. Centers for Disease Control and Prevention. MMWR Recomm Rep 2003;52(RR-2):1-13.
19. Hooks JJ, Gibbs CJ. The foamy viruses. Bacteriol Rev 1975;39:169-85.
20. Canadian Blood Services [homepage on the Internet]. Ottawa, Ontario: The Services; c1998-2006. http://www.blood.ca/CentreApps/Internet/ UW_V502_MainEngine.nsf/page/Home?OpenDocument
21. McMichael AJ, Hanke T. HIV vaccines 1983-2003. Nat Med 2003;9:874-80.
22. von Laer D, Neumann-Haefelin D, Heeney JL, Schweizer M. Lymphocytes are the major reservoir for foamy viruses in peripheral blood. Virology 1996;22:240-4.
23. Gust DA, Gordon TP, Brodie AR, et al. Effect of companions in modulating stress associated with new group formation in juvenile rhesus macaques. Physiol Behav 1996;59:941-5.
24. Falcone V, Leupold J, Clotten J, et al. Sites of simian foamy virus persistence in naturally infected African green monkeys: latent provirus is ubiquitous, whereas viral replication is restricted to the oral mucosa. J Virol 1999;257:7-14.
25. Boneva RS, Switzer WM, Spira T, et al. Human infection with simian foamy viruses: preliminary results from a long-term follow-up study [abstract]. Fourth International Conference on Foamy Viruses; 2002 Mar 14-16; Atlanta, GA.
26. Moebes A, Enssle J, Bieniasz J, et al. Human foamy virus reverse transcription that occurs late in the viral replication cycle. J Virol 1997;71:7305-11.
27. Rethwilm A. The replication strategy of foamy viruses. Curr Top Microbiol Immunol 2003;277:1-26.
28. Gregori L, McCombie N, Palmer D, et al. Effectiveness of leucoreduction for removal of infectivity of transmissible spongiform encephalopathies from blood. Lancet 2004;364:529-31.
29. Canadian Paediatric Society Infectious Diseases and Immunization Committee. Transfusion and risk of infection in Canada: Update 2006. Can J Infect Dis Med Microbiol 2006;17:103-7.
30. Meiering CD, Linial ML. Historical perspectives of foamy virus epidemiology and infection. Clin Microbiol Rev 2001;14:165-76.
31. Donegan E, Stuart M, Niland JC, et al. Infection with human immunodeficiency virus type 1 (HIV-1) among recipients of antibody-positive blood donations. Ann Intern Med 1990;113:733-9.
32. Varghese B, Maher JE, Peterman TA, et al. Reducing the risk of sexual HIV transmission: quantifying the per-act risk for HIV on the basis of choice of partner, sex act, and condom use. Sex Transm Dis 2002;29:38-43.
33. Wilson K, Ricketts MN. Transfusion transmission of vCJD: a crisis avoided? Lancet 2004;364:377-9.